125 related articles for article (PubMed ID: 30530573)
1. Clustering of malignant pleural mesothelioma in asbestos factories: a subgroup analysis in a 29-year follow-up study to identify high-risk industries in Taiwan.
Lee LJ; Lin CK; Pan CH; Cheng Y; Chang YY; Liou SH; Wang JD
BMJ Open; 2018 Dec; 8(12):e021063. PubMed ID: 30530573
[TBL] [Abstract][Full Text] [Related]
2. Malignant pleural mesothelioma treated in Clinic for Pulmonary Diseases and Tuberculosis "Podhrastovi" in ten-year period (from 1998 to 2007).
Cukić V; Ustamujić A; Lovre V; Zutić H; Genjac S; Masić-Zecević M
Bosn J Basic Med Sci; 2008 Nov; 8(4):361-6. PubMed ID: 19125709
[TBL] [Abstract][Full Text] [Related]
3. The incidence of mesothelioma has not decreased for the last twenty years in Southeast region of Anatolia.
Carkanat AI; Abdurrahman A; Abakay O; Cengizhan S; Selimoglu SH; Senyigit A
Afr Health Sci; 2011 Sep; 11(3):346-52. PubMed ID: 22275923
[TBL] [Abstract][Full Text] [Related]
4. Changing trends in mesothelioma: Important lessons for an occupational disease registry.
Barnes H; Hoy RF
Respirology; 2024 Apr; 29(4):269-270. PubMed ID: 38404135
[No Abstract] [Full Text] [Related]
5. Environmental asbestos exposure and clustering of malignant mesothelioma in community: a spatial analysis in a population-based case-control study.
Airoldi C; Magnani C; Lazzarato F; Mirabelli D; Tunesi S; Ferrante D
Environ Health; 2021 Sep; 20(1):103. PubMed ID: 34526026
[TBL] [Abstract][Full Text] [Related]
6. Predictions of Mortality from Pleural Mesothelioma in Italy After the Ban of Asbestos Use.
Oddone E; Bollon J; Nava CR; Bugani M; Consonni D; Marinaccio A; Magnani C; Barone-Adesi F
Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31963601
[TBL] [Abstract][Full Text] [Related]
7. Mortality rates from asbestos-related diseases in Italy during the first year of the COVID-19 pandemic.
Fazzo L; Grande E; Zona A; Minelli G; Crialesi R; Iavarone I; Grippo F
Front Public Health; 2023; 11():1243261. PubMed ID: 38292377
[TBL] [Abstract][Full Text] [Related]
8. The Western Australian Mesothelioma Registry: Analysis of 60 years of cases.
Brims F; Kumarasamy C; Menon L; Olsen N; de Klerk N; Franklin P
Respirology; 2024 Apr; 29(4):288-294. PubMed ID: 38153786
[TBL] [Abstract][Full Text] [Related]
9. A liquid biopsy for detecting circulating mesothelial precursor cells: A new biomarker for diagnosis and prognosis in mesothelioma.
Duong BTV; Wu L; Green BJ; Bavaghar-Zaeimi F; Wang Z; Labib M; Zhou Y; Cantu FJP; Jeganathan T; Popescu S; Pantea J; de Perrot M; Kelley SO
EBioMedicine; 2020 Nov; 61():103031. PubMed ID: 33045471
[TBL] [Abstract][Full Text] [Related]
10. Industry, occupation, and exposure history of mesothelioma patients in the U.S. National Mesothelioma Virtual Bank, 2006-2022.
Gao Y; Mazurek JM; Li Y; Blackley D; Weissman DN; Burton SV; Amin W; Landsittel D; Becich MJ; Ye Y
Environ Res; 2023 Aug; 230():115085. PubMed ID: 36965810
[TBL] [Abstract][Full Text] [Related]
11. Malignant pleural mesothelioma in Italy.
Bianchi C; Bianchi T
Indian J Occup Environ Med; 2009 Aug; 13(2):80-3. PubMed ID: 20386624
[TBL] [Abstract][Full Text] [Related]
12. Effect of Asbestos Consumption on Malignant Pleural Mesothelioma in Italy: Forecasts of Mortality up to 2040.
Oddone E; Bollon J; Nava CR; Consonni D; Marinaccio A; Magnani C; Gasparrini A; Barone-Adesi F
Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34283067
[TBL] [Abstract][Full Text] [Related]
13. Breath Analysis for Early Detection of Malignant Pleural Mesothelioma: Volatile Organic Compounds (VOCs) Determination and Possible Biochemical Pathways.
Di Gilio A; Catino A; Lombardi A; Palmisani J; Facchini L; Mongelli T; Varesano N; Bellotti R; Galetta D; de Gennaro G; Tangaro S
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429446
[TBL] [Abstract][Full Text] [Related]
14. Exhaled Breath Analysis in Diagnosis of Malignant Pleural Mesothelioma: Systematic Review.
Töreyin ZN; Ghosh M; Göksel Ö; Göksel T; Godderis L
Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32050546
[TBL] [Abstract][Full Text] [Related]
15. Asbestos and ship-building: fatal consequences.
Hedley-Whyte J; Milamed DR
Ulster Med J; 2008 Sep; 77(3):191-200. PubMed ID: 18956802
[TBL] [Abstract][Full Text] [Related]
16. Shipbuilding and mesothelioma in Monfalcone, Italy.
Bianchi C; Bianchi T
Indian J Occup Environ Med; 2012 Jan; 16(1):14-7. PubMed ID: 23112501
[TBL] [Abstract][Full Text] [Related]
17. Frequency of Asbestos Exposure and Histological Subtype of Ovarian Carcinoma.
Vidican P; Perol O; Fevotte J; Fort E; Treilleux I; Belladame E; Zavadil J; Fervers B; Charbotel B
Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564776
[TBL] [Abstract][Full Text] [Related]
18. Gluteal muscle metastases from malignant pleural mesothelioma: a case report.
Stirpe E; Bardaro F; Köhl J
Monaldi Arch Chest Dis; 2024 May; ():. PubMed ID: 38722058
[TBL] [Abstract][Full Text] [Related]
19. Breath analysis as a diagnostic and screening tool for malignant pleural mesothelioma: a systematic review.
Brusselmans L; Arnouts L; Millevert C; Vandersnickt J; van Meerbeeck JP; Lamote K
Transl Lung Cancer Res; 2018 Oct; 7(5):520-536. PubMed ID: 30450290
[TBL] [Abstract][Full Text] [Related]
20. The MexTAg collaborative cross: host genetics affects asbestos related disease latency, but has little influence once tumours develop.
Fisher SA; Patrick K; Hoang T; Marcq E; Behrouzfar K; Young S; Miller TJ; Robinson BWS; Bueno R; Nowak AK; Lesterhuis WJ; Morahan G; Lake RA
Front Toxicol; 2024; 6():1373003. PubMed ID: 38694815
[No Abstract] [Full Text] [Related]
[Next] [New Search]
